Matt Abernethy, Officer: Neurocrine Biosciences NBIX Planned sale · Filed 09/14

Trade details

Type: Planned sale notice
Stock: Neurocrine Biosciences NBIX
Person: Matt AbernethyOfficer
Planned sale date: 26/09/14
Filed: 26/09/14

$361K to be sold

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 08/15~10/14

Matt Abernethy's recent trades

Matt AbernethyCFO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$158K
1,352 sh
$158K
Filed 25/02/14
Traded 25/02/13
Matt AbernethyCFO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$140.9K
1,206 sh
$140.9K
Filed 25/02/14
Traded 25/02/13
C. Abernethy MatthewOfficer
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$158.4K
1,352 sh
$158.4K
Filed 25/02/13
Traded 25/02/13
C. Abernethy MatthewOfficer
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$141.3K
1,206 sh
$141.3K
Filed 25/02/13
Traded 25/02/13
Matt AbernethyCFO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$115.9K
980 sh
$115.9K
Filed 25/02/12
Traded 25/02/10